PAVmed (PAVM) News Today $0.79 +0.01 (+1.51%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$0.84 +0.05 (+6.59%) As of 02/21/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA HealthFebruary 20 at 8:31 AM | prnewswire.comPAVmed regains compliance with Nasdaq equity requirementFebruary 18, 2025 | markets.businessinsider.comPAVmed Regains Compliance with Nasdaq Stockholders' Equity RequirementFebruary 18, 2025 | prnewswire.comLucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceFebruary 6, 2025 | prnewswire.comPAVMed faces Nasdaq delisting over share price ruleJanuary 25, 2025 | msn.comPAVmed stock touches 52-week low at $0.57 amid market challengesJanuary 23, 2025 | msn.comLucid Diagnostics Announces Record Quarterly EsoGuard® Test VolumeJanuary 13, 2025 | prnewswire.comPAVmed stock plunges to 52-week low, touches $0.6December 20, 2024 | investing.comLucid Diagnostics partners for esophageal precancer detection for firefightersDecember 19, 2024 | markets.businessinsider.comLucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for FirefightersDecember 19, 2024 | prnewswire.comLucid announces publication on EsoGuard in peer-reviewed journal MedicinaDecember 12, 2024 | markets.businessinsider.comProspective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed PublicationDecember 11, 2024 | prnewswire.comLucid Diagnostics completes convertible debt refinancingDecember 4, 2024 | markets.businessinsider.comLucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term MilestonesDecember 3, 2024 | prnewswire.comLucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA TestNovember 20, 2024 | prnewswire.comLucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNovember 18, 2024 | prnewswire.comPAVmed Third Quarter 2024 Earnings: Misses ExpectationsNovember 17, 2024 | finance.yahoo.comPAVmed Positioned for Growth Despite Q3 Revenue Miss: Buy Rating Affirmed by Anthony VendettiNovember 16, 2024 | markets.businessinsider.comPA Vmed Reports Q3 Gains and Strategic AdvancesNovember 15, 2024 | markets.businessinsider.comQ3 2024 PAVmed Inc Earnings CallNovember 15, 2024 | finance.yahoo.comPAVmed Inc (PAVM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic RestructuringNovember 15, 2024 | finance.yahoo.comPAVmed Inc. (PAVM) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | seekingalpha.comPAVmed Q3 2024 Earnings PreviewNovember 13, 2024 | msn.comLucid Diagnostics Provides Business Update and Third Quarter 2024 Financial ResultsNovember 13, 2024 | prnewswire.comPAVmed's Earnings: A PreviewNovember 12, 2024 | benzinga.comHold Rating Amidst Uncertainty and Transitional Challenges in Q3 2024November 11, 2024 | markets.businessinsider.comIcecure Medical’s ProSense System Gains Favorable FDA Panel Recommendation and Strong Financial Position Supports Buy RatingNovember 9, 2024 | markets.businessinsider.comLucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed PublicationNovember 7, 2024 | prnewswire.comLucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue DriversNovember 5, 2024 | prnewswire.comLucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 13, 2024October 30, 2024 | prnewswire.comBarfresh Food Group: Strong Growth Prospects and Strategic Initiatives Justify Buy RatingOctober 26, 2024 | markets.businessinsider.comLucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA TestOctober 15, 2024 | prnewswire.comPAVmed Subsidiary Veris Health Granted $1.8 Mln NIH Funding To Enhance Cancer CareOctober 10, 2024 | markets.businessinsider.comPAVmed Subsidiary, Veris Health, Awarded $1.8 Million NIH Grant to Enhance Cancer CareOctober 10, 2024 | prnewswire.comLucid Diagnostics to Participate in the 2024 Maxim Healthcare Virtual SummitOctober 9, 2024 | prnewswire.comLucid Diagnostics to Join Global Medtech Leaders at The MedTech Conference 2024October 8, 2024 | prnewswire.comPAVmed (NASDAQ:PAVM) Stock Quotes, Forecast and News SummaryOctober 7, 2024 | benzinga.comOptimistic Buy Rating for PAVmed Amid Strategic Positioning and Promising Financial OutlookSeptember 26, 2024 | markets.businessinsider.comAmerican Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer TestSeptember 24, 2024 | prnewswire.comPAVmed moves to deconsolidate Lucid DiagnosticsSeptember 18, 2024 | investing.comPAVmed Announces Efforts to Regain Compliance with Nasdaq Listing RequirementsSeptember 16, 2024 | prnewswire.comPAVmed Inc. (PAVM) interactive stock chart – Yahoo FinanceSeptember 12, 2024 | nz.finance.yahoo.comPAVmed Inc. (PAVM) Interactive Stock Chart - Yahoo FinanceSeptember 11, 2024 | ca.finance.yahoo.comLucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World CongressSeptember 10, 2024 | prnewswire.comLucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile HealthSeptember 3, 2024 | prnewswire.comLucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and CancerAugust 20, 2024 | prnewswire.comPAVmed Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagAugust 15, 2024 | finance.yahoo.comTalks continue over train drivers’ pay disputeAugust 14, 2024 | msn.comLucid Diagnostics Inc. (NASDAQ:LUCD) Q2 2024 Earnings Call TranscriptAugust 13, 2024 | msn.comPAVmed Provides Business Update and Second Quarter 2024 Financial ResultsAugust 13, 2024 | finance.yahoo.com Get PAVmed News Delivered to You Automatically Sign up to receive the latest news and ratings for PAVM and its competitors with MarketBeat's FREE daily newsletter. Email Address PAVM Media Mentions By Week PAVM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PAVM News Sentiment▼0.350.60▲Average Medical News Sentiment PAVM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PAVM Articles This Week▼31▲PAVM Articles Average Week Get PAVmed News Delivered to You Automatically Sign up to receive the latest news and ratings for PAVM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Daxor News Today Precision Optics News Today Envoy Medical News Today PolyPid News Today Beyond Air News Today SurgePays News Today DIH Holding US News Today IRIDEX News Today NEXGEL News Today Retractable Technologies News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PAVM) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAVmed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PAVmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
